Browsing Tag
National Company Law Tribunal
7 posts
Sanofi Consumer Healthcare India Q1 FY2025 results: PAT climbs 12.9% post-demerger, stock holds premium valuation
Sanofi Consumer Healthcare India Q1 FY2025 PAT rose 12.9% to ₹500 million. Read stock analysis, investor sentiment, and growth outlook post demerger.
SEBI settlement: ICICI Securities resolves compliance case for Rs 40 lakh
ICICI Securities, one of India’s leading brokerage firms, recently settled a regulatory dispute with the Securities and Exchange…
Lumax Auto Technologies achieves record Q2FY25 revenue; announces Greenfuel acquisition
Lumax Auto Technologies Limited, a major player in the Indian automotive components sector, reported remarkable financial results for…
Sadhana Nitro Chem wins NCLT approval for strategic acquisition of Calchem Industries
In a significant step towards market expansion, Sadhana Nitro Chem Ltd. (SNCL) has secured approval from the National…
Aditya Birla Capital’s explosive move: RBI’s green light sparks massive finance merger
In a major development, Aditya Birla Capital Limited (ABCL) announced that the Reserve Bank of India (RBI) has…
Vedanta Limited’s dramatic shake-up: Major demerger set to reshape India’s energy and mineral landscape
Vedanta Limited, a heavyweight in critical minerals and energy, has just unveiled a game-changing strategy that will transform…
Tega Industries gets NCLT nod for acquisition of McNally Sayaji Engineering
Tega Industries Limited said that it has secured approval from the Indian National Company Law Tribunal (NCLT) for…